Previous Section
Clinical Trials
21. Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.
- Author
- Giles F; Rizzieri D; Karp J; Vey N; Ravandi F; Faderl S; Khan KD; Verhoef G; Wijermans P; Advani A; Roboz G; Kantarjian H; Bilgrami SF; Ferrant A; Daenen SM; Karsten V; Cahill A; Albitar M; Mufti G; O'Brien S;
- Institution
- The University of Texas M.D. Anderson Cancer Center, Department of Leukemia, Houston, TX 77030, USA. frankgiles@aol.com
- Journal
- J Clin Oncol. 2007 Jan 1;25(1):25-31. Epub 2006 Dec 4.
- Abstract URL
- Click here to view abstract
22. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
- Author
- Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP;
- Institution
- Department of Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA. ayashl@karmanos.org
- Journal
- Am J Hematol. 2007 Jan;82(1):6-14.
- Abstract URL
- Click here to view abstract
23. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
- Author
- Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ;
- Institution
- Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Republic of Korea.
- Journal
- Am J Hematol. 2007 Jan;82(1):1-5.
- Abstract URL
- Click here to view abstract
24. Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia.
- Author
- Lehrnbecher T; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Creutzig U;
- Institution
- Pediatric Hematology and Oncology, University of Frankfurt, Germany, and Children's Cancer Research Institute, St Anna Kinderspital, Vienna, Austria. thomas.lehrnbecher@kgu.de
- Journal
- Blood. 2007 Feb 1;109(3):936-43. Epub 2006 Sep 28.
- Abstract URL
- Click here to view abstract
25. High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
- Author
- Taksin AL; Legrand O; Raffoux E; de Revel T; Thomas X; Contentin N; Bouabdallah R; Pautas C; Turlure P; Reman O; Gardin C; Varet B; de Botton S; Pousset F; Farhat H; Chevret S; Dombret H; Castaigne S;
- Institution
- Departement d'Hematologie et Oncologie, Hopital Mignot, Versailles, Universite de Versailles-Saint Quentin en Yvelines, France.
- Journal
- Leukemia. 2007 Jan;21(1):66-71. Epub 2006 Oct 19.
- Abstract URL
- Click here to view abstract
26. A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.
- Author
- Lancet JE; Gojo I; Gotlib J; Feldman EJ; Greer J; Liesveld JL; Bruzek LM; Morris L; Park Y; Adjei AA; Kaufmann SH; Garrett-Mayer E; Greenberg PL; Wright JJ; Karp JE;
- Institution
- H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA. lancetje@moffitt.org
- Journal
- Blood. 2007 Feb 15;109(4):1387-94. Epub 2006 Nov 2.
- Abstract URL
- Click here to view abstract
27. HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.
- Author
- Herr AL; Labopin M; Blaise D; Milpied N; Potter M; Michallet M; Heit W; Ferrara F; Esteve J; Arcese W; Ehninger G; Rowe JM; Kobbe G; Rosselet A; Bunjes D; Rio B; Brune M; Nagler A; Gorin NC; Frassoni F; Rocha V;
- Institution
- Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
- Journal
- Leukemia. 2007 Jan;21(1):129-35. Epub 2006 Nov 23.
- Abstract URL
- Click here to view abstract
28. A multicenter randomized, double-blind, placebo-controlled late-phase II/III study of recombinant human interleukin 11 in acute myelogenous leukemia.
- Author
- Usuki K; Urabe A; Ikeda Y; Ohashi Y; Mizoguchi H; Takaku F;
- Institution
- Division of Hematology, NTT Kanto Medical Center, Tokyo, Japan. usuki@kmc.mhc.east.ntt.co.jp
- Journal
- Int J Hematol. 2007 Jan;85(1):59-69.
- Abstract URL
- Click here to view abstract
29. Post-remission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy - results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.
- Author
- Gardin C; Turlure P; Fagot T; Thomas X; Terre C; Contentin N; Raffoux E; de Botton S; Pautas C; Reman O; Bourhis JH; Fenaux P; Castaigne S; Michallet M; Preudhomme C; de Revel T; Bordessoule D; Dombret H;
- Institution
- Department of Hematology, Hopital Avicenne, Bobigny, France.
- Journal
- Blood. 2007 Mar 6;.
- Abstract URL
- Click here to view abstract
30. A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.
- Author
- Harousseau JL; Lancet JE; Reiffers J; Lowenberg B; Thomas X; Huguet F; Fenaux P; Zhang S; Rackoff W; De Porre P; Stone R;
- Institution
- Service d'Hematologie, Hotel Dieu, Nantes, France.
- Journal
- Blood. 2007 Mar 9;.
- Abstract URL
- Click here to view abstract
